Insulin Resistance in Polycystic Ovary Syndrome: Mechanistic Insights and Therapeutic Perspectives Independent of Obesity.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanisms and management without systematic methodology
PubMed 42541004 · doi:10.4103/gmit.GMIT-D-25-00185
What was done
This narrative review summarizes the pathophysiological mechanisms, clinical consequences, and multidisciplinary management strategies for insulin resistance in polycystic ovary syndrome (PCOS), focusing on manifestations independent of obesity.
What was found
The abstract reports no numerical data or quantitative outcomes. It qualitatively describes that PCOS with insulin resistance presents more severely than PCOS without it, that severity is comparatively lower in non-obese individuals, and that combining lifestyle interventions (physical activity, whole-food nutrition, sleep, mental health support), pharmaceutical agents, and dietary supplements improves PCOS symptoms.
Why it matters
It emphasizes that insulin resistance is a key clinical target across the PCOS spectrum, including in non-obese patients, and promotes multifaceted intervention.
Limits
As an unsystematic narrative review, it presents no original clinical data or meta-analytic pooling, omits quantitative effect sizes in the abstract, and lacks formal study selection or risk-of-bias evaluation criteria.
Cited by
- context Approximately 80% of PCOS patients have insulin resistance.